Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Zilico Limited logo — Real-time medical diagnostics

Zilico Limited

Real-time medical diagnostics

Founded 2006 United Kingdom Manchester, United Kingdom 7 employees Grant Total: $23.42M Biotechnology, Health Care

General Information

Company Name Zilico Limited
Founded Year 2006
Location United Kingdom Manchester, United Kingdom
Employees 7
Industries Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Zilico Limited. To contact Zilico Limited, visit zilico.co.uk.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Zilico Limited compare?

A PDF of Zilico Limited and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Zilico Limited soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Zilico Limited

Zilico Limited is a UK-based company specializing in real-time medical diagnostics targeting specific clinical needs. Its flagship product, ZedScan™, utilizes Electrical Impedance Spectroscopy (EIS) to enhance the detection of cervical intraepithelial neoplasia (CIN), thereby increasing diagnostic accuracy and delivering health economic benefits. The company's patented EIS technology exploits the varying electrical resistivity associated with normal, pre-cancerous, and cancerous tissue, suggesting its potential applicability to detect and diagnose other types of neoplasia. Founded in 2006, Zilico operates in the Biotechnology and Health Care industries from its headquarters in the United Kingdom.

In a recent development, the company secured a £884.24K grant investment on 01 May 2019 from SBRI Healthcare, underscoring investor interest in the promising technology and its potential for positive impact in the healthcare sector.

Business keywords: Medical Diagnostics, Real-time Technology, Electrical Impedance Spectroscopy, Cervical Intraepithelial Neoplasia, Diagnostic Accuracy, Health Economic Benefits, Patented Technology, Neoplasia Detection, Disease Diagnosis, Clinical Needs, Cellular Structure, Cancer Detection, Rapid Diagnosis, Reproducible Detection, Healthcare Innovation

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Grant £884.24K 1
SBRI Healthcare
SBRI Healthcare
01 May 2019
Corporate Round $19.00M 2
Deepbridge Capital MaxHealth Medicine Group
Deepbridge Capital, MaxHealth Medicine Group
04 Feb 2018
Venture Round Undisclosed 1
IP Group
IP Group
30 Jun 2017
Series A $1.80M 1
VentureFounders
VentureFounders
29 Jun 2016
Venture Round Undisclosed 1
Innovate UK
Innovate UK
23 Jul 2014
Venture Round £750.00K 1
The North West Fund
The North West Fund
30 Oct 2012
Venture Round £985.00K 3
Spark Ventures The North West Fund
Spark Ventures, The North West Fund +1
21 Jun 2012

Zilico Limited Alternatives & Competitors

View All Alternatives
Zilico Limited vs
EMPE Diagnostics
EMPE Diagnostics Sweden

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited...

Series A
27 employees
Biotechnology, Health Care
Zilico Limited vs
Hera Biotech
Hera Biotech United States

Advancing the Standard of Care in Women's Health Diagnostics

Series A
12 employees
Biopharma, Biotechnology
Zilico Limited vs
Harae Dx Corp.
Harae Dx Corp. United States

Harae Dx is developing the worlds first low-cost portable Automated cancer detection system

Series A
6 employees
Biotechnology, Health Care
View all alternatives

FAQ About Zilico Limited

Real-time medical diagnostics
Zilico Limited was founded in 2006.
Zilico Limited is headquartered in Manchester, United Kingdom.
Zilico Limited operates in Biotechnology and Health Care. Its work centres on Medical Diagnostics, Real-time Technology, Electrical Impedance Spectroscopy and Cervical Intraepithelial Neoplasia.
Zilico Limited has approximately 7 employees.
Zilico Limited has completed 7 funding rounds, raising a total of $23.42M. The latest funding stage is Grant.
Top alternatives and competitors to Zilico Limited include EMPE Diagnostics, Hera Biotech, Harae Dx Corp., Cyted Health, Fast Biotechnologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Zilico Limited and EMPE Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Zilico Limited, https://bouncewatch.com/company/zilico-limited, updated 19 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout